Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Bitonti

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Antimicrobial Agents and Chemotherapy|August 11, 1990
Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylaseA J Bitonti, T L Byers, T L Bush, et al.
Journal of Medicinal Chemistry|May 1, 1990
Polyamine analogues with antitumor activityM L Edwards, N J Prakash, D M Stemerick, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domainA J Bitonti, J A Dumont, F G Salituro, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Cancer Research|March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductaseA J Bitonti, J A Dumont, T L Bush, et al.
Oncology Research|January 1, 1997
Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731)R D Woessner, D E Loudy, C D Wallace, et al.
Biochemical Pharmacology|May 20, 1998
Clomiphene analogs with activity in vitro and in vivo against human breast cancer cellsR J Baumann, T L Bush, D E Cross-Doersen, et al.
Experimental Cell Research|January 10, 1996
A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenograftsP S Wright, D Cross-Doersen, J P Th'ng, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Antimicrobial Agents and Chemotherapy|August 11, 1990
Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylaseA J Bitonti, T L Byers, T L Bush, et al.
Journal of Medicinal Chemistry|May 1, 1990
Polyamine analogues with antitumor activityM L Edwards, N J Prakash, D M Stemerick, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domainA J Bitonti, J A Dumont, F G Salituro, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Cancer Research|March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductaseA J Bitonti, J A Dumont, T L Bush, et al.
Oncology Research|January 1, 1997
Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731)R D Woessner, D E Loudy, C D Wallace, et al.
Biochemical Pharmacology|May 20, 1998
Clomiphene analogs with activity in vitro and in vivo against human breast cancer cellsR J Baumann, T L Bush, D E Cross-Doersen, et al.
Experimental Cell Research|January 10, 1996
A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenograftsP S Wright, D Cross-Doersen, J P Th'ng, et al.
Pageof 7